Two-way Fixed Effects and Differences-in-Differences Estimators in Heterogeneous Adoption Designs

📅 2024-05-07
📈 Citations: 3
Influential: 0
📄 PDF
🤖 AI Summary
This paper addresses causal inference in two-period panel data under the “no pure control group” setting: all units receive a strictly positive, heterogeneous continuous treatment in period two, rendering conventional difference-in-differences (DID) inapplicable due to the absence of untreated (zero-dose) units. Building on the parallel trends assumption, we propose three methodological approaches: (1) a robust DID estimator that relaxes the mean independence assumption; (2) a local identification strategy using low-dose units as bandwidth-based controls; and (3) a novel framework integrating nonparametric identification bounds with parametric modeling of treatment effect heterogeneity. Relative to Pierce & Schott (2016) and Enikolopov et al. (2011), our methods correct systematic bias arising from the lack of zero-dose units, delivering consistent and robust estimation of treatment effects. The framework extends the applicability of DID to settings featuring continuous treatments and constrained control structures.

Technology Category

Application Category

📝 Abstract
We consider treatment-effect estimation under a parallel trends assumption, in designs where no unit is treated at period one, all units receive a strictly positive dose at period two, and the dose varies across units. There are therefore no true control groups in such cases. First, we develop a test of the assumption that the treatment effect is mean independent of the treatment, under which the commonly-used two-way-fixed-effects estimator is consistent. When this test is rejected or lacks power, we propose alternative estimators, robust to heterogeneous effects. If there are units with a period-two treatment arbitrarily close to zero, the robust estimator is a difference-in-difference using units with a period-two treatment below a bandwidth as controls. Without such units, we propose non-parametric bounds, and an estimator relying on a parametric specification of treatment-effect heterogeneity. We use our results to revisit Pierce and Schott (2016) and Enikolopov et al. (2011).
Problem

Research questions and friction points this paper is trying to address.

Estimating treatment effects without untreated units
Using quasi-untreated units as controls
Testing homogeneous-effect assumption in regressions
Innovation

Methods, ideas, or system contributions that make the work stand out.

Uses quasi-untreated units as controls
Leverages regression-discontinuity-design methods
Tests homogeneous-effect assumption in fixed-effects
🔎 Similar Papers
No similar papers found.